Antidepressant drug repurposed for patients with coronavirus infection. In a preliminary study of COVID-19 patients with the mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make...
BY SARAH POLUS COVID-19 has been linked to a greater risk of developing mental health disorders, a new study from Britain’s Oxford University states. The report published in The Lancet peer-reviewed medical journal found that 20 percent of COVID-19 survivors, or 1 in 5, will receive a first-time mental health diagnosis within 90 days of infection. Among the...
By REUTERS and NATALIE RAHHAL US HEALTH EDITOR PUBLISHED: 12:39 EDT, 8 October 2020 Giving coronavirus patients an arthritis drug, on top of the antiviral, remdesivir, reduces their odds of dying by 35 percent, the drug’s maker, Eli Lilly announced Thursday. The National Institutes of Health (NIH) sponsored study found that the combination worked best for patients sick...
Doctors at the University of Alabama at Birmingham (UAB) are enrolling patients in an international clinical trial to find out if inhaled nitric oxide benefits those with novel coronavirus (COVID-19) who have severely damaged lungs. Right now, there are no approved treatments for the illness caused by COVID-19. The severe form of lung failure—acute respiratory...
